JSH 23, NFkappaB transcriptional activity inhibitor (ab144824)
Overview
-
Product name
JSH 23, NFkappaB transcriptional activity inhibitor -
Description
NFκB transcriptional activity inhibitor -
Biological description
NFκB transcriptional activity inhibitor (IC50 = 7.1 μM). Inhibits LPS-induced nuclear translocation of NFκB. Does not affect IκB degradation. Potentiates the antitumor effects of cisplatin (ab141398). Shows neuroprotective effects in vivo. -
Purity
> 99% -
CAS Number
749886-87-1 -
Chemical structure
Properties
-
Chemical name
4-Methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine -
Molecular weight
240.34 -
Molecular formula
C16H20N2 -
PubChem identifier
16760588 -
Storage instructions
Store at -20°C (desiccating conditions). -
Solubility overview
Soluble in ethanol to 75 mM and in DMSO to 100 mM -
Handling
Toxic, refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
CC1=CC(=C(C=C1)NCCCC2=CC=CC=C2)N -
Source
Synthetic
-
Research areas
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (2)
ab144824 has been referenced in 2 publications.
- Kubota M et al. Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation. PLoS One 14:e0225066 (2019). PubMed: 31703091
- Lai J et al. Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell proliferation and collagen accumulation. Biochim Biophys Acta Mol Basis Dis 1865:2403-2410 (2019). PubMed: 31102789
